Stephen D Weigand
Overview
Explore the profile of Stephen D Weigand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
13086
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cogswell P, Wiste H, Weigand S, Therneau T, Griswold M, Braunstein J, et al.
Alzheimers Dement
. 2025 Feb;
21(2):e14629.
PMID: 39989078
Introduction: Limited data exist on the utility of plasma biomarkers to predict incident abnormal amyloid positron emission tomography (PET). In this study we evaluate the association of plasma Alzheimer's disease...
2.
Bornhorst J, Lundgreen C, Weigand S, Figdore D, Wiste H, Griswold M, et al.
Neurology
. 2025 Jan;
104(3):e210287.
PMID: 39823562
Background And Objectives: Chronic kidney disease (CKD) is known to be associated with increased plasma phosphorylated tau217 (p-tau217) concentrations, potentially confounding the utility of plasma p-tau217 measurements as a marker...
3.
Carlos A, Weigand S, Pham N, Petersen R, Jack Jr C, Dickson D, et al.
Alzheimers Dement
. 2025 Jan;
21(2):ealz14516.
PMID: 39821594
Introduction: Greater white matter hyperintensities (WMHs) on magnetic resonance imaging (MRI) are seen with transactive response DNA-binding protein 43 (TDP-43) pathology in frontotemporal lobar degeneration (FTLD-TDP). WMH associations with TDP-43...
4.
Gakh O, Wilkins J, Guo Y, Popescu B, Weigand S, Kalinowska-Lyszczarz A, et al.
Acta Neuropathol Commun
. 2024 Sep;
12(1):146.
PMID: 39256864
Multiple sclerosis (MS) is a leading cause of non-traumatic disability in young adults. The highly dynamic nature of MS lesions has made them difficult to study using traditional histopathology due...
5.
Badihian N, Tosakulwong N, Weigand S, Ali F, Clark H, Stierwalt J, et al.
Parkinsonism Relat Disord
. 2024 Sep;
127:107109.
PMID: 39222570
Background: A definitive diagnosis of progressive supranuclear palsy (PSP) can only be established through neuropathological evaluations where four cardinal tau lesions are identified. Relationships between regional tau burden and disease...
6.
Josephs K, Tosakulwong N, Weigand S, Graff-Radford J, Schwarz C, Senjem M, et al.
Sci Transl Med
. 2024 Jul;
16(757):eado8076.
PMID: 39047115
[F]-Flortaucipir positron emission tomography (PET) is considered a good biomarker of Alzheimer's disease. However, it is unknown how flortaucipir is associated with the distribution of tau across brain regions and...
7.
Carlos A, Weigand S, Duffy J, Clark H, Utianski R, Machulda M, et al.
Brain Commun
. 2024 Apr;
6(2):fcae097.
PMID: 38572268
Two variants of semantic dementia are recognized based on the laterality of temporal lobe involvement: a left-predominant variant associated with verbal knowledge impairment and a right-predominant variant associated with behavioural...
8.
Robinson C, Goodrich A, Weigand S, Pham N, Carlos A, Buciuc M, et al.
J Int Neuropsychol Soc
. 2024 Mar;
30(6):575-583.
PMID: 38525671
Objective: To determine whether poorer performance on the Boston Naming Test (BNT) in individuals with transactive response DNA-binding protein 43 pathology (TDP-43+) is due to greater loss of word knowledge...
9.
Jack Jr C, Wiste H, Algeciras-Schimnich A, Weigand S, Figdore D, Lowe V, et al.
Alzheimers Dement
. 2024 Jan;
20(3):2143-2154.
PMID: 38265198
Background: We compared the ability of several plasma biomarkers versus amyloid positron emission tomography (PET) to predict rates of memory decline among cognitively unimpaired individuals. Methods: We studied 645 Mayo...
10.
Josephs K, Koga S, Tosakulwong N, Weigand S, Nha Pham T, Baker M, et al.
Free Neuropathol
. 2023 Dec;
4.
PMID: 38093787
TAR DNA binding protein 43 (TDP-43) pathology is a defining feature of frontotemporal lobar degeneration (FTLD). In FTLD-TDP there is a moderate-to-high burden of morphologically distinctive TDP-43 immunoreactive inclusions distributed...